cover image - Mosby's 2028 Nursing Drug Reference - Elsevier eBook on VitalSource, 41st Edition
ISBN: 9780443401336
Copyright: 2028
Page Count: 1504
Imprint: Mosby
List Price: $44.99

Mosby's 2028 Nursing Drug Reference - Elsevier eBook on VitalSource, 41st Edition

by Linda Skidmore-Roth, RN, MSN, NP

Elsevier eBook on VitalSource

cover image - Mosby's 2028 Nursing Drug Reference - Elsevier eBook on VitalSource, 41st Edition
ISBN: 9780443401336
Copyright: 2028
Page Count: 1504
Imprint: Mosby
List Price: $44.99

$44.99

Or $0.00 with a valid access code
Not Yet Available
Coming Soon!
Expected availability date: 02-26-2027
Mosby's 2028 Nursing Drug Reference makes it easy to find the most vital information on the drugs you administer most frequently. More than 5,000 drugs are profiled ― including more than 25 new entries for drugs recently approved by the FDA. And no other drug guide places a higher emphasis on patient safety, with Black Box Warnings for dangerous adverse reactions, High Alerts for drugs with the greatest risk, and a focus on both common and life-threatening side effects. From nursing pharmacology expert Linda Skidmore-Roth, this perennial bestseller proves there is a difference in drug guides.
    • Provide 20-30 monographs on newly released, FDA-approved drugs and up-to-date content on the latest drug therapies for print edition
    • Adding at least 20 new Website-only drug monographs to the existing website-only drug monographs
    • Each monograph read and updated as necessary with new interactions, precautions, alerts, patient teaching instructions, and other need-to-know information included throughout as needed. Current information helps nurses feel confident in the accuracy of the information and helps prevent medication dispensing errors
    • Full-color text with content on more than 5,000 generic and trade name drugs providing coverage for almost every drug a student is likely to encounter in clinicals
    • Black Box warning feature alerts students to FDA warnings of potentially life-threatening reactions
    • Safety Alert feature icon highlights the most critical interactions and side-effects that students must be aware of during clinicals
    • Bold heading and details on IV drug administration so students can easily find appropriate dosage and IV administration instructions to help them administer these drugs safely
    • Logical organization of side effects information: organized by body system and are identified as common or life threatening, showing nurses what signs to watch for during assessments
    • Nursing Process steps used as the framework to organize all nursing care information helps students learn how to easily and completely incorporate the nursing process into their clinical experiences
    • Logical alphabetical organization by generic name with both trade and generic names in the index, which gives users quick access to specific drugs
    • Complete pharmacokinetic information organized in a table and explains the mechanism and absorption of the drug as well as the action, duration and excretion of the drug
    • All the drugs found in the appendixes have cross-reference headers in the body of the book, making it easier for users to find the drug content they need quickly and makes it less likely that a user will think a drug is missing if it is not in the body of the book
    • More than 100 Website-only drug monographs for lesser used medications
  • Drug categories Alpha-adrenergic blockers Anesthetics--general/local Antacids Anti-alzheimer agents Antianginals Antianxiety agents Antiasthmatics Anticholinergics Anticoagulants Anticonvulsants Antidepressants Antidiabetics Antidiarrheals Antidysrhythmics Antiemetics Antifungals (systemic) Antihistamines Antihypertensives Antiinfectives Antilipidemics Antineoplastics Antiparkinson agents Antiplatelets Antipsychotics Antipyretics Antiretrovirals Antituberculars Antitussives/expectorants Antivirals Beta-adrenergic blockers Bone resorption inhibitors Calcium channel blockers Cardiac glycosides Cholinergics Cholinergic blockers Corticosteroids Diuretics Histamine H2 antagonists Immunosuppressants Laxatives Neuromuscular blocking agents Nonsteroidal antiinflammatories Opioid analgesics Salicylates Sedatives/hypnotics Skeletal muscle relaxants Thrombolytics Thyroid hormones Vasodilators Vitamins Individual drugs in A-Z Format

    Appendices (NOTE: ALL appendices will be moved to the QR-coded website.)
    A. Selected new drugs
    B. Recent FDA drug approvals
    C. Ophthalmic, otic, nasal, and topical products
    D. Vaccines and toxoids
    E. Antitoxins and antivenins
    F. Herbal products
    G. Combination products
    H. Medications that may be inappropriate for geriatric patients
    I. Drugs metabolized by known P450’s
    J. Safety in handling chemotherapeutic agents
    K. High-alert drugs
    L. Controlled substance chart
    M. Immunization schedules for children and adolescents
    N. High-alert Canadian medications
    O. Canadian controlled substance chart
    P. Canadian recommended immunization schedules for infants and children
    Q. FDA pregnancy categories
    R. Weights and equivalents
    S. Abbreviations
  • Linda Skidmore-Roth, RN, MSN, NP, Consultant, Littleton, Colorado; Former Nursing Faculty, New Mexico State University, Las Cruces, New Mexico; El Paso Community College, El Paso, Texas, USA
    • Ways of Reading
      • The appearance of the text and page layout can be modified according to the capabilities of the reading system (font family and font size, spaces between paragraphs, sentences, words, and letters, as well as color of background and text)
      • This e-publication is accessible to the full extent that the file format and types of content allow, on a specific reading device, by default, without necessarily including any additions such as textual descriptions of images or enhanced navigation
      • All content can be read as read aloud speech or dynamic braille
    • Conformance
      • The certifier's credential is https://bornaccessible.benetech.org/certified-publishers/
      • For detailed accessibility information, see Elsevier's website at https://www.elsevier.com/about/accessibility
      • For queries regarding accessibility information, contact [email protected]
      • The publication was certified on 20-11-2025
    • Navigation
      • Table of contents to all chapters of the text via links
      • Page list to go to pages from the print source version
    • Rich Content
      • No information is available
    • Hazards
      • No information is available
    • Product Content
      • No information is available
    • Legal Considerations
      • No information is available
    • Additional Accessibility Information
      • Content is enhanced with ARIA roles to optimize organization and facilitate navigation
      • Page breaks included from the original print source
      • For readers with color vision deficiency, use of color (e.g., in diagrams, graphics and charts, in prompts, or on buttons inviting a response) is not the sole means of graphical distinction or of conveying information
      • The body text is presented with a contrast ratio of at least 4.5:1 (or 3:1 for large/heading text)
      • Ultra-high contrast between text and background
      • E-publication includes basic navigation (usually less detailed than TOC-based navigation)
      • Where links, controls or buttons are included in the content, the purpose or functionality of each link, control or button is apparent from the associated text alone - or where it is unclear, separate link, control or button descriptions are provided
      • All (or substantially all) textual matter is arranged in a single logical reading order (including text that is visually presented as separate from the main text flow, e.g., in boxouts, captions, tables, footnotes, endnotes, citations, etc.). Non-textual content is also linked from within this logical reading order. (Purely decorative non-text content can be ignored).
      • Where interactive content is included in the product, controls are provided (e.g., for speed, pause and resume, reset) and labelled to make their use clear.
      • The language of the text has been specified (e.g., via the HTML or XML lang attribute) to optimise text-to-speech (and other alternative renderings), both at the whole document level and, where appropriate, for individual words, phrases or passages in a different language.

$44.99

Or $0.00 with a valid access code
Not Yet Available
Coming Soon!
Expected availability date: 02-26-2027